About Chimera TQM 

Deborah Griffin, Founder of Chimera TQM, has over 25 years of experience in cellular therapy and laboratory science, including both minimally and more-than-minimally manipulated products. Special projects have included Translational Research, Clinical Research and Process Improvement for novel cellular therapy products such as hepatocytes and adipocytes.

 

Deborah was a FACT inspector for over a decade and has performed almost 20 external inspections. In addition, she was responsible for the FACT inspections of three independently accredited facilities at UPMC, the adult hematopoietic stem cell lab, the pediatric hematopoietic stem cell lab and a dendritic cell vaccine production facility, and successfully led them through 10 inspections. She was involved in many committees at ISCT, including Chair of the North America Legal and Regulatory Committee and co-founder of the Early Stage Professionals Committee as well as the Editor of the Society’s newsletter, the Telegraft.

 

Formerly the Director of Quality Management for Cell Therapies of the Cell Therapies Facility at Moffitt Cancer Center in Tampa, FL, USA, Deborah is passionate about sharing knowledge and helping others, including being an apheresis donor in the past. 

 

She has also served as the Manager of Quality Assurance and Regulatory Affairs for Cellular Therapy at the Hillman Cancer Center, University of Pittsburgh Medical Center, in Pittsburgh, PA, USA.

​

When working with clients, Deborah digs into how they are currently working in order to guide them in the best direction for success. 

 

Deborah's superpower is writing Standard Operating Procedures, so if you struggle with writing, she can help.